HAILI CAMPANELLA: Open Payments
NPI 1184151193 · WAUKEGAN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$592 in 32 payments from 6 companies in 2025. Trend: 2023 $67 · 2024 $225 · 2025 $592
Food & beverage: $592
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $235 |
| Otsuka America Pharmaceutical, Inc. | 13 | $216 |
| Neos Therapeutics, LP | 2 | $43 |
| Tris Pharma Inc | 2 | $34 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
Products named: VRAYLAR, REXULTI, Adzenys XR-ODT, Dyanavel XR, Auvelity, TRINTELLIX.
Industry payments across IL — which companies pay providers there.
